Hypersensitivity reactions to chemotherapy: an EAACI Position Paper-Reference-Cited by-同舟云学术

Hypersensitivity reactions to chemotherapy: an EAACI Position Paper

Published:2021-10-26 Issue:2 Volume:77 Page:388-403
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Pagani Mauro¹^ORCID,Bavbek Sevim²^ORCID,Alvarez‐Cuesta Emilio³,Berna Dursun Adile⁴^ORCID,Bonadonna Patrizia⁵,Castells Mariana⁶^ORCID,Cernadas Josefina⁷,Chiriac Anca⁸,Sahar Hamadi⁹,Madrigal‐Burgaleta Ricardo¹⁰¹¹^ORCID,Sanchez Sanchez Soledad¹²

Affiliation:

1. Department of Medicine Medicine Ward C. Poma Mantova HospitalASST Mantova Mantova Italy

2. Division of Immunology and Allergy Department of Chest Diseases Ankara University School of Medicine Ankara Turkey

3. Allergy Division, Former Head Ramon y Cajal University Hospital Madrid Spain

4. Department of Immunology and Allergic Diseases Recep Tayyip Erdoğan University Rize Turkey

5. Allergy Unit Azienda Ospedaliera di Verona Verona Italy

6. Division of Rheumatology, Immunology and Allergy Department of Medicine Brigham and Women's HospitalHarvard Medical School Boston Massachusetts USA

7. Department of Allergy and Clinical Immunology Medical University, H. S. Joao Porto Portugal

8. Division of Allergy Department of Pulmonology Hôpital Arnaud de VilleneuveUniversity Hospital of Montpellier Montpellier France

9. The Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts USA

10. Allergy & Severe Asthma Service St Bartholomew's Hospital'sBarts Health NHS Trust London UK

11. Drug Desensitisation Centre Catalan Institute of Oncology (ICO) Bellvitge University Hospital Barcelona Spain

12. Division of Allergy & Clinical Immunology Department of Medicine University Hospital Complex of A Coruna A Coruna Spain

Funder

European Academy of Allergy and Clinical Immunology

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15113

Reference104 articles.

1. World Health Organizationwww.who.int/health‐topics/cancer Overview

2. Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl‐bis(beta‐chloroethyl)amine hydrochloride and tris(beta‐chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. By Louis S. Goodman, Maxwell M. Wintrobe, William Dameshek, Morton J. Goodman, Alfred Gilman and Margaret T. McLennan;Goodman LS;JAMA,1984

3. De Vita JuniorVT LawrenceTS&RosenbergSA.Principles and practice of Oncology 11th edition 2018; cap 17 "Cancer Immunotherapy" pag 218 Wolter Kluver Health Editor.

4. Fatal anaphylaxis in the United States, 1999-2010: Temporal patterns and demographic associations

5. Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid Desensitization to Antitumoral Agents. Result from a Retrospective Study, DESARCh;Hospital Pharmacy;2024-09-05

2. Quercetin: A Flavonoid with Diverse Chemo Preventive Properties against Cancer;Quercetin - Effects on Human Health;2024-09-04

3. Basophil activation test is a complementary tool in the diagnosis of immediate reactions to platinum salts and taxanes;Allergy;2024-08-31

4. Rapid Drug Desensitization and Management of Breakthrough Reactions in Pediatric Patients;ASTHMA ALLERGY IMMUN;2024

5. Mirvetuximab after anaphylaxis to Paclitaxel: A case report;Gynecologic Oncology Reports;2024-08